Alzheimer's drug shows promise in early results of study

Shares of Biogen and other drugmakers researching Alzheimer's disease soared early Wednesday after Japan's Eisai Co. said its potential treatment appeared to slow the fatal disease's progress in a late-stage study

Related Keywords

Graig Suvannavejh ,Japan Eisai Co ,Alzheimer Association ,Drug Administration ,Eisai Co ,Mizuho Securities ,